Navigation Links
Golden Meditech Repurchases Shares

HONG KONG, Dec. 21, 2011 /PRNewswire-Asia-FirstCall/ -- Golden Meditech Holdings Limited ("Golden Meditech" or the "Group," - 801.HK; 910801.TW), China's leading integrated healthcare enterprise, today announced that the Group has repurchased a total of 9,940,000 shares in December 2011, equivalent to 0.49% of the Group's total outstanding shares at a weighted average price of HK$0.84 per share.Mr. KAM Yuen, Chairman and Chief Executive Officer of the Group, said, "Our recently announced interim results for the first six months of the financial year points to a positive outlook for our operations especially in the healthcare services segment, while our medical devices segment, being a leading name in the medical devices industry in China has also been performing in-line with our expectations.  As a result of a volatile global capitals market, however, we believe the Company's current share price do not adequately reflect the true value of the underlying operation.  Hence to reciprocate our shareholders, the Company has repurchased its shares from the open market.  We will continue to monitor our share price and undertake appropriate actions to repurchase shares when appropriate in consideration to the benefit of our shareholders.

Mr. Kam continued, "As the founding shareholder of the Company, my family and I have been accumulating the Company's shares from the market and now own 21.64%.  I believe that once the market stabilises, the intrinsic value of the Company's will be better reflected in its share price."

About Golden Meditech Holdings LimitedGolden Meditech Holdings Limited is China's leading integrated-healthcare devices and service operator, and the first medical device enterprise that was publicly listed outside of the PRC on the Stock Exchange of Hong Kong Limited (HKEx) and the Taiwan Stock Exchange (TSE).  Golden Meditech is a first-mover in China, having established dominant positions in medical devices and healthcare services markets over the years, thanks to its strengths in innovation and market expertise and the ability to capture emerging market opportunities.  Going forward, the Group will continue to pursue a leading position in China's healthcare industry both through organic growth and strategic expansion.

For inquiries, please contact the Investor Relations Department:Golden Meditech Holdings LimitedAddress:

48/F, Bank of China Tower, 1 Garden Road, Central, Hong KongTel:  



SOURCE Golden Meditech Holdings Limited
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartSine® Technologies Now Exclusive Provider of Lifesaving AEDs to Golden LivingCenters
2. Golden Meditech FY2011-12 Interim Results
3. Golden Meditech Chairman Increases Stake in Company
4. Golden Meditech Increase Stake in NYSE-listed Affiliate - China Cord Blood Corporation to 40.9%
5. Golden Meditech Disposes of 2.0% Stake in FunTalk China for US$15 Million
6. Golden Meditech Celebrates Grand Opening of Taiwan Representative Office
7. Golden Meditech FY2010-11 Annual Results
8. Golden Meditech Acquires Shanghai East International Medical Centre
9. Golden Meditech to Increase Stake in NYSE-listed Affiliate -- China Cord Blood Corporation to 39.5%
10. Golden Meditech Chairman Increases Stake in Company
11. Fenwal, Golden Meditech Complete Definitive Agreement to Form Joint Venture in China
Post Your Comments:
(Date:11/30/2015)... Nov. 30, 2015  Novartis will demonstrate the strength ... th American Society of Hematology (ASH) Annual Meeting. ... as well as supportive care, including key findings in ... cell therapies. The ASH Annual Meeting will be held ... Novartis Oncology . "We will be presenting ...
(Date:11/30/2015)... BOSTON , November 30, 2015 ... medicines directed at up to 10 G protein-coupled receptor ... PFE ) to research and develop potential new medicines ... targets across multiple therapeutic areas. --> Heptares ... development company and wholly-owned subsidiary of Sosei Group Corporation ...
(Date:11/30/2015)... TEL AVIV, Israel , November 30, 2015 /PRNewswire/ ... EMITF ) ("Elbit" or the "Company") announced today that it ... Ministry of Food and Drug Safety (MFDS) has approved ... behavioral disorders. --> --> ... presenting a non-invasive treatment alternative that combines two technologies: ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... ... While powdered supplements and drinks can reduce food preparation time, locating the ... has found an easy to keep track of the scoop. , He developed a ... a canister or other container handy and readily accessible. As such, it prevents the ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... announced at the Radiology Society of North America (RSNA) annual meeting, being held ... 60% growth from 2014. Throughout 2015, the company has completed installations for ...
(Date:11/30/2015)... ... November 30, 2015 , ... Volpara Solutions ... density assessment and enterprise analytics solutions, here at the 101st Annual Radiological ... booth #2377). Volpara’s quantitative breast imaging tools enable personalized measurements of volumetric ...
(Date:11/30/2015)... ... ... It’s inevitable that everyone will experience death in his or her lifetime. Whether ... among us. It is your perspective, however, that determines how you view death in ... Sky understands that she may see death more frequently than most. As she was ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... the speakers for “Value-Based Payer-Provider Partnerships: Three Case Studies,” an upcoming Dec. ... care arrangements: Essentia Health and UCare, MissionPoint Health Partners, and Intel Corp. ...
Breaking Medicine News(10 mins):